The GIFT Nifty futures, which is an early indicator of the Nifty50 index stocks, was trading lower by 42 points at 24,964, indicating that the domestic benchmark indices are likely to make a muted start on Monday.

Earlier on Friday, 6 October, the Domestic benchmark indices S&P BSE Sensex gained by 224 points or 0.28%, and settled at 81,207, while the Nifty50 traded 0.23% lower or 58 points, closing at 24,894.

Here are some stocks that are likely to remain in focus on 6 October.

Lupin: The US Food and Drug Administration (USFDA) classified its inspection of Lupin’s Pithampur Unit-2 facility as Official Action Indicated (OAI) following a July 8–17, 2025, review that resulted in four observations in Form-483. Lupin is actively working with the USFDA to address the compliance issues. Meanwhile, the company launched Liraglutide injection in the US, which is a bioequivalent to Victoza by Novo Nordisk Inc., an adjunct to diet and exercise for improving glycemic control in adults.

AstraZeneca Pharma: AstraZeneca Pharma India received approval from the Central Drugs Standard Control Organisation (CDSCO) to import and market its cancer therapy drug Enhertu (trastuzumab deruxtecan) for an additional medical indication.

Ceigall India: Ceigall India secured Letters of Award worth Rs 712.16 crore and Rs 597 crore from the Maharashtra State Electricity Distribution Company to act as a Solar Power Developer (SPD) for solar photovoltaic projects of 190 MW and 147 MW (AC), respectively. These projects, awarded under the Mukhyamantri Saur Krushi Vahini Yojana 2.0 Scheme, will be developed across four and two districts in Maharashtra.

Infosys: Infosys announced a partnership with Telenor Shared Services (TSS) to standardise HR processes and enhance employee productivity and experience. The collaboration will implement Oracle Cloud Human Capital Management (HCM) across TSS’s operations.

Tata Steel: The Office of the Deputy Director of Mines, Jajpur, issued a demand notice of Rs 2,410.89 crore to Tata Steel, citing a shortfall in chrome ore dispatches from the Sukinda Chromite Block during its fifth year of operations. The demand includes the sale value of the shortfall and the appropriation of performance security.

Feeling overwhelmed by the markets? Let Unicorn Signals be your guide. Our user-friendly app simplifies complex data and provides actionable trading signals. Download the app today and trade with confidence!